Company Team
Peptide Med-Chem, Delivery and CMC
Dr. Ved Srivastava
- CTO at Perpetual Medicines and Ex-VP of Chemistry at Atkis Oncology. Previously, VP of Peptide Chemistry at Intarcia Therapeutics, Head of Peptide Chemistry at GSK; and peptide scientist at Amylin (AZ)
- Ex-President of the American Peptide Society (2019-2021)
- Over 25 years of experience in drug discovery and development in metabolic diseases, CNS, and inflammation
- Significantly participated in the development Symlin™, Byetta™, and Bydeureo™, first- in-class medicines for diabetes
Structural Biology
Dr. Zongchao Jia
- Expert in structural biology with over 25 years of experience in protein structure-function studies, kinases and phosphatases, calcium-binding proteins, and proteins from human pathogens
- Professor of Biochemistry, Queen’s University
- Ph.D. from University of Saskatchewan, post-doctoral training at the University of Oxford
Peptide Chemistry & Virology
Dr. Wuyuan Lu
- Over 30 years of research experience in antimicrobial peptides, peptide chemistry and biochemistry, virology
- Currently professor at Maryland University, Greenebaum Cancer Center
- Ph.D. in Biochemistry from Purdue University; Postdoc research in the Scripps Institute and the University of Chicago
Peptide Chemistry and GPCR Drug Discovery
Dr. John Mayer
- Over 30 years of experience in natural peptide synthesis and GPCR drug discovery with focus on endocrine/diabetes therapeutics
- Advanced six molecules into clinical trials
- Currently, research Scientist in the Molecular, Cellular, and Developmental Biology Department at the University of Colorado, Boulder
- Ex-head of peptide discovery groups of Amgen & Lilly Research Labs. Principal Scientist at Novo Nordisk
MD Simulation & Machine Learning
Dr. Yu-Shan Lin
- Expert in molecular dynamics simulation and machine learning for rapid structure prediction of cyclic peptides on a large scale
- Associate Professor in the Department of Chemistry at Tufts University with over 14 years of research experience
- Professor Lin’s lab focuses on understanding and designing structures and properties of peptides, in particular cyclic and other restrained peptides
- Ph.D. in Chemistry from UW– Madison in 2009 and postdoc from Stanford as a Bio-X postdoctoral fellow
Dr. Rumin Zhang
- 30+ yrs of successful multidisciplinary drug discovery research experience
- Global Health Drug Research and Development Center CSO;Former Vice President of Wollastra Therapeutics and Vice President of Raphael Pharmaceuticals in the United States
- Ph.D. in Biochemistry and Biophysics from State University of New York at Buffalo
Dr. Weiyue Lu
- Director, Professor of Pharmacy, and Doctoral Supervisor of Shanghai Fukang Targeted Drug Research Center at Fudan University
- Former Vice Dean and Party Secretary of the School of Pharmacy, Fudan University
- Director of Shanghai Pharmaceutical Association; Project flexible cooperation expert
Dr. Philip Dawson
- Dean of Graduate and Postdoctoral Studies at Scripps Research Institute and Professor of Chemistry
- Former President of the American Peptide Association
- Postdoctoral fellow at California Institute of Technology
Dr. Changyou Zhan
- Expert of the National Youth Thousand Talents Program; Winner of the National Science Fund for Outstanding Young People
- Professor at Fudan University;Outstanding Discipline Leader of Shanghai Health and Family Planning System
- Postdoctoral fellow at the University of Maryland; Project flexible cooperation expert
Dr. Gerard Manning
- Former Director and Chief Scientist of Genentech's Bioinformatics and Computational Biology division
- Visiting Scientist, University College Cork, Ireland
- Ph.D. in Biochemistry from Stanford University
PepLib aims to promote the development and accessibility of innovative peptide drugs, benefiting global patients and human health while keeping costs low.
Copyright©2023 Zonsen PepLib Biotech Inc. This website supports IPV6
Business License